Gunn 2020.

Methods	Randomised controlled trial
Participants	Participants taking antidepressants for 12 months or longer. Mild or no symptoms of depression as assessed by the PHQ9 (< 10). No depressive episodes in last 12 months or history of recurrent MDD; stable on ADs; low risk of self‐harm
Interventions	Intervention 1: personalised tapering schedule with the support of an online de‐prescribing tool, which will monitor progress, and of GP Intervention 2: usual care plus attention control through signposting to an educational fact sheet about antidepressants
Outcomes	‐ unknown
Notes	Trial duration: 5 years Recruitment starts in 2021. Study will end in June 2024 Contact information: cath.kaylorhughes@unimelb.edu.au